Cleared Abbreviated

K121662 - VECTTOR VT-200

K121662 is an FDA 510(k) clearance for VECTTOR VT-200, manufactured by Alan Neuromedical Technologies, LLC. The device is a Class 2 Neurology device with product code LIH cleared through the Abbreviated 510(k) pathway after a 169-day FDA review.

K121662 · Alan Neuromedical Technologies, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2012
Decision
169d
Days
Class 2
Risk

K121662 is an FDA 510(k) clearance for the VECTTOR VT-200. Classified as Interferential Current Therapy (product code LIH), Class II - Special Controls.

Submitted by Alan Neuromedical Technologies, LLC (Corpus Christi, US). The FDA issued a Cleared decision on November 21, 2012 after a review of 169 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Alan Neuromedical Technologies, LLC devices

FDA 510(k) Submission Details - K121662

510(k) Number K121662 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 2012
Decision Date November 21, 2012
Days to Decision 169 days
Submission Type Abbreviated
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
21d slower than avg
Panel avg: 148d · This submission: 169d
Pathway characteristics
Standards-based clearance path.

LIH Device Classification - Class 2, Special Controls

Product Code LIH Interferential Current Therapy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - LIH Interferential Current Therapy

All 35
Devices cleared under the same product code (LIH) and FDA review panel - the closest regulatory comparables to K121662.
Vecttor VT-300
K231575 · Artaflex, Inc. · Feb 2024
ETD4000
K202725 · Therasigma, LLC · Mar 2021
Avid IF2
K183692 · Vision Quest Industries Inc./Dba VQ Orthocare · Jun 2019
EVERYWAY INTERFERNTIAL STIMULATOR, MODEL IF-908
K110509 · Everyway Medical Instruments Co.,Ltd · Jun 2011
MAX-IF1000
K100246 · Bio Protech, Inc. · Nov 2010
IF TRUE SINE INTERFERENTIAL STIMULATOR, WL-2206D
K092763 · Well-Life Healthcare Limited · Oct 2009